Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVERSE: Mifepristone for Treatment-Resistant PTSD
NCT06689254Phase 2Recruiting
- Start
- Nov 2024
- Primary completion
- Sep 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mifepristone in post-traumatic stress disorder (PTSD). Started Nov 2024; status: recruiting.
02
Drugs
mifepristone
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT06689254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06689254.